Loss of function of Adducin 3 (ADD3) causes abnormal development and impaired barrier function of human and mouse bile duct cells resulting in increased incidence and severity of Biliary Atresia
Theme-based Research Scheme 2021 (T12-712/21-R); Health and Medical Research Fund (06172096; 03143476); RGC CERG Grant 2019/20 (17105119) to VCHL; Commissioned HMRF (PR-HKU-1) to PKHT.
Authors
- Abraham Ka Chung Wai (ORCID: https://orcid.org/0000-0001-9984-8156)
- Yongqin Ye (ORCID: https://orcid.org/0000-0003-2414-7990)
- Clara Sze-Man Tang (ORCID: https://orcid.org/0000-0003-0265-2638)
- Jeong Ho Ha (ORCID: https://orcid.org/0000-0003-1245-1207)
- Niwei Yan (ORCID: https://orcid.org/0000-0002-7420-5346)
- Yim Cheung
- Yuelan Zheng
- Hailong Liu (ORCID: https://orcid.org/0000-0002-6181-2577)
- Zhongluan Wu
- Bhy Chung (ORCID: https://orcid.org/0000-0003-2382-5681)
- Paul KH Tam
- Man‐Ting So
- Kenneth KY Wong
- Vincent Chi Hang Lui (ORCID: https://orcid.org/0000-0002-1758-8854)
Institutions
- Chinese University of Hong Kong (HK)
- University of Macau (MO)
- University of Hong Kong - Shenzhen Hospital (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- EBioMedicine
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1016/j.ebiom.2025.106052
- Primary Topic
- Drug Transport and Resistance Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00